News from ECHA
| Restriction proposal on chromium(VI) substances to protect health We are proposing an EU-wide restriction on certain hexavalent chromium, Cr(VI), substances. The aim is to reduce the harmful effects of these carcinogenic chemicals for both workers and the public. Our proposal introduces a ban on Cr(VI) substances, except in certain use categories when they meet defined limits for worker exposure and environmental emissions. The restriction could prevent up to 17 tonnes of Cr(VI) from being released into the environment and avoid up to 195 cancer cases each year. |
|---|
|
|---|
|
|---|
|
ECHA
IT systems maintenance break on 9-14 May We will carry out some maintenance work on our IT tools and systems. The following services will not be available from Friday 9 May at 08:00 to Wednesday 14 May 2025 until 11:00 (Helsinki time): REACH-IT, R4BP 3 and IUCLID Cloud services;ECHA Submission portal, including Poison centres notification system (PCN), Substances of concern in products (SCIP), EFSA applications for plant protection products (PPP); andSystem-to-system submission service.ePIC will be available during the maintenance but with limited functionalities.
We apologise for the inconvenience. Assessment of regulatory needs report published Report for the following substance group is now available on our website: Primary diaminobenzenes and derivativesIf you have questions or feedback related to the assessment work, you can send them to us using this webform. |
|---|
|
|---|
|
|---|
|
Biocides
More than 500 people joined our Biocides Stakeholders’ Workshop Our Biocides Workshop, held on 29 and 30 April, brought together companies, authorities, NGOs, academia, international organisations, and the interested public both in Helsinki and online.
If you missed the event or wish to revisit the programme, the recording is available on our event webpage.
Thank you for participating, and we look forward to future collaborations. New recommendations for in situ generated active substances We have published a new document clarifying the information requirements and risk assessment principles for in situ generated active substances, their precursors and biocidal products. These recommendations, endorsed by our Biocidal Products Committee Working Groups, aim to clarify the concepts of in situ generation and advise on how to assess these substances. Mark 4 November 2025 in your calendars to join our webinar about in situ generated active substances and their products.
In situ generated active substances are formed from a biocidal product during its use, rather than being intentionally added to the product. |
|---|
|
|---|
|
|---|
|
EU Observatory for Nanomaterials (EUON)
Call for study proposals extended The European Union Observatory for Nanomaterials is looking for topics for upcoming studies aimed at addressing knowledge gaps on nanomaterials within the EU market.
We have extended the deadline for proposals. Submit yours by 14 May 2025. |
|---|
|
|---|
|
|---|
|
Board of Appeal
Appeal on compliance check decision related to EOGRTS dismissed ECHA’s Board of Appeal has dismissed the appeal in case A-003-2024 that concerns a follow-up to a compliance check.
In its compliance check decision, ECHA required the Appellant to submit an extended one-generation reproductive toxicity study (EOGRTS), including cohorts 2A, 2B and 3 under the REACH Annex X. In the follow-up assessment, the Agency rejected the requested study submitted by the Appellant.
The Board of Appeal found that ECHA did not err in assessing that the dose level of the Appellant’s EOGRTS was not set appropriately high following the OECD test guide 443. Additionally, the Board of Appeal agreed that the T-cell dependent antibody response (TDAR) was unreliable. |
|---|
|
|---|
|
|---|
